SB431542
目录号:S1067 Purity: 99.99%
SB431542是一种有效的,选择性ALK5抑制剂,无细胞试验中IC50为94 nM,对ALK5的作用比对p38、MAPK和其他激酶强100倍。
CAS: 301836-41-9
客户使用Selleck的SB431542发表文献716篇
- Nature, 2024 10.1038/s41586-024-08332-w
- Nature, 2024 10.1038/s41586-024-07067-y
- Cell, 2024 S0092-8674(24)00638-X
- Nat Methods, 2024 10.1038/s41592-024-02172-2
- Nat Biotechnol, 2024 10.1038/s41587-024-02360-7
- Cell Stem Cell, 2024 S1934-5909(24)00094-8
- Nat Cell Biol, 2024 10.1038/s41556-024-01487-8
- Nature, 2023 613(7944):550-557
- Nature, 2023 620(7975):863-872
- Signal Transduct Target Ther, 2023 8(1):369
- Cell Discov, 2023 9(1):52
- Protein Cell, 2023 14(5):337-349
- Nature, 2022 605(7909):325-331
- Cell, 2022 185(26):4937-4953.e23
- Cancer Cell, 2022 S1535-6108(22)00312-9
- Cell Discov, 2022 8(1):121
- Adv Mater, 2022 e2106829
- Cell Stem Cell, 2022 29(7):1031-1050.e12
- Nat Cancer, 2022 3(9):1105-1122
- Blood, 2022 blood.2021014304
- Nat Med, 2021 27(3):426-433
- Cancer Cell, 2021 S1535-6108(21)00492-X
- Cancer Cell, 2021 39(3):407-422.e13
- Cell Res, 2021 10.1038/s41422-020-00458-6
- Cell Discov, 2021 7(1):81
- Nat Cell Biol, 2021 23(6):652-663
- Nature, 2020 580(7801):124-129.
- Nature, 2020 10.1038/s41586-020-2630-0
- Cell Discov, 2020 6(1):89
- Immunity, 2020 S1074-7613(20)30278-8
- Immunity, 2020 52(2):328-341
- Cell Stem Cell, 2020 S1934-5909(20)30544-0
- Mil Med Res, 2020 7(1):42
- Immunity, 2019 50(1):121-136.e5
- Immunity, 2019 51(4):671-681
- Immunity, 2019 51(5):885-898
- Nat Neurosci, 2019 22(3):386-400
- Nat Neurosci, 2019 22(3):374-385
- Cell Stem Cell, 2019 24(3):447-461.e8.
- Cell Stem Cell, 2019 24(5):802-811
- Protein Cell, 2019 10.1007/s13238-019-0610-7
- Nat Metab, 2019 1(2):222-235
- Nat Med, 2018 24(10):1568-1578
- Nature, 2018 557(7704):247-251
- Nature, 2018 563(7733):701-704
- Protein Cell, 2018 9(11):945-965
- Nat Med, 2017 23(9):1036-1045
- Cell Res, 2017 27(4):483-504
- Sci Immunol, 2017 2(11)
- Cell Stem Cell, 2017 20(3):397-406
- Cell Stem Cell, 2017 20(5):659-674
- Nat Cell Biol, 2017 19(10):1274-1285
- Nature, 2016 10.1038/nature17408
- Nat Immunol, 2016 17(8):976-84
- Nature, 2015 13;524(7564):234-8.
- Circ Res, 2015 116(1):23-34
- Nat Methods, 2014 11(8):855-60
- Mol Cancer, 2011 10:66
- Neural Regen Res, 2025 20(2):587-597
- Toxicol In Vitro, 2025 103:105972
- Nat Commun, 2024 15(1):8547
- Nat Commun, 2024 15(1):1351
- Nat Commun, 2024 15(1):668
- Nat Commun, 2024 15(1):583
- Nucleic Acids Res, 2024 gkae707
- Brain, 2024 awae379
- Mol Ther, 2024 S1525-0016(24)00382-4
- Gut Microbes, 2024 16(1):2297897
- Dev Cell, 2024 S1534-5807(24)00326-5
- EMBO Mol Med, 2024 10.1038/s44321-024-00174-3
- Proc Natl Acad Sci U S A, 2024 121(13):e2309925121
- EMBO Mol Med, 2024 16(4):870-884
- Mol Psychiatry, 2024 10.1038/s41380-024-02578-6
- Am J Hum Genet, 2024 111(11):2392-2410
- Cancer Lett, 2024 600:217153
- Cell Death Dis, 2024 15(4):302
- Cell Death Dis, 2024 15(12):892
- Cell Rep, 2024 43(3):113883
- Cell Rep, 2024 43(9):114700
- Cell Rep, 2024 43(1):113664
- Cell Prolif, 2024 e13732.
- J Tissue Eng, 2024 15:20417314241265198
- Mol Metab, 2024 84:101943
- Cell Mol Life Sci, 2024 81(1):427
- Cell Mol Life Sci, 2024 81(1):50
- JCI Insight, 2024 9(16)e175103
- JCI Insight, 2024 9(9)e168792
- EMBO Rep, 2024 25(5):2188-2201
- Stem Cell Res Ther, 2024 15(1):83
- Stem Cell Res Ther, 2024 15(1):133
- Stem Cell Res Ther, 2024 15(1):226
- Genes Dis, 2024 11(5):101285
- Ecotoxicol Environ Saf, 2024 285:117051
- Glia, 2024 72(6):1165-1182
- Neural Regen Res, 2024 19(1):205-211
- Neural Regen Res, 2024 19(4):908-914
- Cells, 2024 13(4)313
- Stem Cell Reports, 2024 19(7):973-992
- Stem Cell Reports, 2024 19(2):196-210
- Stem Cell Reports, 2024 S2213-6711(24)00216-9
- iScience, 2024 27(9):110613
- iScience, 2024 27(6):109911
- iScience, 2024 27(5):109748
- iScience, 2024 27(3):109166
- iScience, 2024 27(8):110430
- iScience, 2024 27(6):109967
- Biomolecules, 2024 14(2)189
- J Endocrinol Invest, 2024 10.1007/s40618-023-02267-1
- Zool Res, 2024 45(2):233-241
- Pestic Biochem Physiol, 2024 200:105831
- Viruses, 2024 16(4)552
- Biology (Basel), 2024 13(9)684
- Heliyon, 2024 10(13):e33736
- Placenta, 2024 147:68-77
- Cell Transplant, 2024 33:9636897241228026
- Transl Vis Sci Technol, 2024 13(7):2
- Reprod Sci, 2024 10.1007/s43032-024-01590-z
- Pharmacol Res Perspect, 2024 12(1):e1160
- BMC Ophthalmol, 2024 24(1):409
- Sci Adv, 2024 10(5):eadk1034
- Stem Cell Res, 2024 77:103414
- Res Sq, 2024 rs.3.rs-5349885
- Bioengineering (Basel), 2024 11(3)255
- Cell Genom, 2024 4(8):100606
- Bioengineering (Basel), 2024 11(12)1282
- Cell Regen, 2024 13(1):21
- Cell Regen, 2024 13(1):9
- Cell Rep Methods, 2024 4(11):100897
- Commun Med (Lond), 2024 4(1):259
- STAR Protoc, 2024 5(4):103384
- Cell Regen, 2024 13(1):17
- bioRxiv, 2024 2024.01.15.574730
- Bioact Mater, 2023 22:518-534
- Nat Commun, 2023 14(1):3801
- Nat Commun, 2023 14(1):7632
- J Clin Invest, 2023 133(11)e164472
- J Adv Res, 2023 S2090-1232(23)00031-0
- Int J Biol Sci, 2023 19(13):4004-4019
- Int J Biol Sci, 2023 19(13):4259-4277
- Cell Death Dis, 2023 14(12):822
- Biofabrication, 2023 15(4).
- Cell Death Dis, 2023 14(8):557
- Cell Rep, 2023 42(6):112546
- Cell Rep, 2023 42(6):112647
- Cell Rep, 2023 10.1016/j.celrep.2023.113459
- Mol Ther Nucleic Acids, 2023 33:683-697
- Cell Rep, 2023 42(6):112566
- Cell Rep, 2023 42(6):112593
- Cell Prolif, 2023 10.1111/cpr.13540
- Cell Prolif, 2023 56(5):e13434
- Mol Metab, 2023 77:101798
- Phytomedicine, 2023 118:154942
- Aging Cell, 2023 e13790.
- Stem Cell Res Ther, 2023 10.1186/s13287-023-03546-7
- Stem Cell Res Ther, 2023 14(1):63
- Front Immunol, 2023 14:1258074
- NPJ Regen Med, 2023 8(1):19
- Cell Death Discov, 2023 9(1):384
- Cells, 2023 12(12)1624
- Stem Cell Reports, 2023 10.1016/j.stemcr.2023.10.015
- iScience, 2023 26(12):108532
- iScience, 2023 26(12):108466
- Int J Mol Sci, 2023 24(3)2338
- Int J Mol Sci, 2023 24(4)3398
- Int J Mol Sci, 2023 10.3390/ijms242115535
- Int J Mol Sci, 2023 24(4)3587
- Int J Mol Sci, 2023 24(14)11401
- Int J Mol Sci, 2023 24(15)12445
- Front Cell Dev Biol, 2023 11:1172385
- Pharmaceutics, 2023 10.3390/pharmaceutics15102456
- Front Cell Neurosci, 2023 17:1134090
- J Cell Mol Med, 2023 27(21):3235-3246
- Cancers (Basel), 2023 15(9)2498
- Int J Oncol, 2023 63(1)88
- Front Mol Biosci, 2023 10:1232573
- Sci Rep, 2023 13(1):12137
- Development, 2023 150(16)dev201141
- Development, 2023 150(14)dev201386
- Dis Model Mech, 2023 16(1)dmm049727
- Neurogastroenterol Motil, 2023 e14681.
- Genes (Basel), 2023 14(5)957
- Cell Transplant, 2023 32:9636897231178460
- Cell Transplant, 2023 32:9636897231198172
- BMC Musculoskelet Disord, 2023 24(1):907
- Sci Adv, 2023 9(34):eadh2501
- J Vis Exp, 2023 (202).
- Bio Protoc, 2023 10.21769/BioProtoc.4870
- STAR Protoc, 2023 4(2):102266
- bioRxiv, 2023 2023.12.22.573117
- bioRxiv, 2023 2023.03.06.531220
- JBMR Plus, 2023 7(5):e10737
- STAR Protoc, 2023 4(2):102164
- bioRxiv, 2023 2023.06.12.544654
- Cell Regen, 2023 12(1):27
- Zhejiang Da Xue Xue Bao Yi Xue Ban, 2023 52(5):558-566
- bioRxiv, 2023 10.1101/2023.05.31.543173
- bioRxiv, 2023 10.1101/2023.08.04.552012
- bioRxiv, 2023 2023.08.17.553739
- Cell Regen, 2023 12(1):15
- bioRxiv, 2023 2023.08.30.555581
- Nat Commun, 2022 13(1):3147
- Nat Commun, 2022 13(1):6239
- Nat Commun, 2022 13(1):3419
- Neuron, 2022 110(19):3106-3120.e7
- Adv Sci (Weinh), 2022 e2203315.
- Adv Sci (Weinh), 2022 e2103939
- Adv Sci (Weinh), 2022 e2106075
- Adv Sci (Weinh), 2022 e2104299
- Acta Pharm Sin B, 2022 12(2):821-837
- Redox Biol, 2022 50:102248
- Cancer Res, 2022 82(9):1774-1788
- Proc Natl Acad Sci U S A, 2022 119(6)e2114006119
- J Immunother Cancer, 2022 10(2)e003655
- Clin Transl Med, 2022 12(8):e995
- J Nanobiotechnology, 2022 20(1):519
- Int J Biol Sci, 2022 18(5):1989-2002
- Sci China Life Sci, 2022 10.1007/s11427-021-2035-2
- Cell Death Dis, 2022 13(5):440
- Cell Rep, 2022 39(12):110994
- Cell Rep, 2022 39(2):110646
- Cell Prolif, 2022 e13215
- Cell Prolif, 2022 10.1111/cpr.13244
- Cell Prolif, 2022 e13336
- J Tissue Eng, 2022 13:20417314221122123
- Oncogene, 2022 41(19):2719-2733
- Phytomedicine, 2022 104:154277
- Phytomedicine, 2022 99:154018
- Diabetes, 2022 71(8):1660-1678
- Elife, 2022 11e76707
- Elife, 2022 11e70341
- Stem Cell Res Ther, 2022 13(1):120
- Cell Biosci, 2022 12(1):181
- Fluids Barriers CNS, 2022 19(1):87
- Br J Pharmacol, 2022 10.1111/bph.15795
- NPJ Regen Med, 2022 7(1):69
- Matrix Biol, 2022 111:226-244
- Transl Psychiatry, 2022 12(1):130
- Cell Biol Toxicol, 2022 1-19
- Cells, 2022 11(8)1269
- Stem Cells Transl Med, 2022 11(7):715-726
- Cells, 2022 11(3)399
- Cells, 2022 11(15)2387
- Cells, 2022 11(9)1411
- Stem Cell Reports, 2022 17(12):2674-2689
- Stem Cell Reports, 2022 S2213-6711(21)00645-7
- iScience, 2022 25-10:104971
- Front Pharmacol, 2022 13:1016552
- Int J Mol Sci, 2022 23(14)7586
- Int J Mol Sci, 2022 23(15)8507
- Int J Mol Sci, 2022 23-1911333
- Int J Mol Sci, 2022 24(1)701
- Front Pharmacol, 2022 13:926433
- J Cell Physiol, 2022 10.1002/jcp.30903
- Int J Mol Sci, 2022 23(8)4213
- Int J Mol Sci, 2022 23(23)15408
- Int J Mol Sci, 2022 23(10)5603
- J Physiol, 2022 10.1113/JP282585
- Front Cell Dev Biol, 2022 10:985298
- Front Cell Neurosci, 2022 16:906270
- Cancers (Basel), 2022 14(15)3672
- Stem Cells, 2022 sxac046
- Cancers (Basel), 2022 14(3)639
- Eur J Pharmacol, 2022 929:175116
- Zool Res, 2022 43(6):911-922
- Front Mol Neurosci, 2022 15:859349
- J Biol Chem, 2022 298(4):101748
- Stem Cell Rev Rep, 2022 10.1007/s12015-022-10339-7
- Viruses, 2022 14(6)1308
- Biomedicines, 2022 10(7)1625
- Development, 2022 149(19)dev200413
- Sci Rep, 2022 12(1):8928
- Sci Rep, 2022 12(1):7
- Invest Ophthalmol Vis Sci, 2022 63(10):14
- Invest Ophthalmol Vis Sci, 2022 63(4):2
- Regen Ther, 2022 19:77-87
- Stem Cells Int, 2022 2022:1396735
- Cell Cycle, 2022 1-16
- Dis Model Mech, 2022 15(12)dmm049471
- Front Physiol, 2022 13:823661
- Heliyon, 2022 8(10):e11135
- BMC Cancer, 2022 22(1):166
- PLoS One, 2022 17(11):e0278158
- Exp Mol Pathol, 2022 S0014-4800(21)00139-8
- Exp Eye Res, 2022 S0014-4835(22)00020-3
- Neural Plast, 2022 2022:7382327
- Infect Immun, 2022 90(7):e0066321
- Acupunct Med, 2022 10.1177/09645284221085278
- Sci Adv, 2022 8(15):eabk2376
- Cell Reprogram, 2022 10.1089/cell.2022.0014
- Stem Cell Res, 2022 64:102890
- Stem Cell Res, 2022 61:102771
- J Biomed Res, 2022 36(2):127-140
- STAR Protoc, 2022 3(3):101638
- Immunohorizons, 2022 6(7):416-429
- Cell Genom, 2022 2(11)100177
- Curr Protoc, 2022 2(10):e568
- Nat Commun, 2021 12(1):1670
- Nat Commun, 2021 12(1):1929
- Nat Commun, 2021 12(1):4640
- Neuron, 2021 109(12):1949-1962.e6
- J Clin Invest, 2021 131(6)136098
- Adv Sci (Weinh), 2021 8(21):e2102354
- Adv Sci (Weinh), 2021 e2103495
- Theranostics, 2021 11(16):7879-7895
- Cell Death Differ, 2021 10.1038/s41418-021-00897-7
- Proc Natl Acad Sci U S A, 2021 118(29)e2101270118
- Mol Psychiatry, 2021 10.1038/s41380-021-01023-2
- Environ Sci Technol, 2021 55(4):2440-2451
- Adv Healthc Mater, 2021 e2101580
- PLoS Biol, 2021 19(2):e3001122
- Angiogenesis, 2021 10.1007/s10456-021-09770-0
- ACS Appl Mater Interfaces, 2021 13(2):3199-3208
- Biofabrication, 2021 13(4)
- Cell Death Dis, 2021 12(1):74
- Cell Rep, 2021 36(2):109360
- Cell Rep, 2021 36(11):109718
- Cell Rep, 2021 37(1):109774
- Mol Ther Nucleic Acids, 2021 23:294-309
- Cell Rep, 2021 34(12):108895
- Cell Rep, 2021 37(9):110063
- Cell Rep, 2021 35(13):109290
- Cell Rep, 2021 35(7):109159
- Oncogene, 2021 10.1038/s41388-021-02128-2
- Phytomedicine, 2021 84:153513
- Phytomedicine, 2021 92:153719
- Elife, 2021 10e63021
- EMBO Rep, 2021 e51781
- Biomed Pharmacother, 2021 143:112204
- Breast Cancer Res, 2021 23(1):107
- Front Immunol, 2021 12:707899
- Transl Psychiatry, 2021 11(1):479
- Biomacromolecules, 2021 10.1021/acs.biomac.1c01086
- Cells, 2021 11(1)124
- Cells, 2021 10(7)1671
- Cells, 2021 10(1)E134
- Cells, 2021 10(1)74
- Cells, 2021 10(10)2746
- Stem Cell Reports, 2021 S2213-6711(21)00309-X
- iScience, 2021 24(12):103400
- iScience, 2021 24(10):103193
- Front Bioeng Biotechnol, 2021 9:788987
- Front Cell Dev Biol, 2021 9:726866
- Front Cell Dev Biol, 2021 9:702462
- Front Cell Dev Biol, 2021 9:712224
- Front Cell Dev Biol, 2021 9:712124
- Front Cell Dev Biol, 2021 9:713503
- J Neurosci, 2021 JN-RM-1930-20
- Zool Res, 2021 42(3):377-388
- Stem Cell Rev Rep, 2021 10.1007/s12015-020-10103-9
- FASEB J, 2021 35(3):e21263
- FASEB J, 2021 35(10):e21883
- Front Aging Neurosci, 2021 13:736580
- FASEB J, 2021 35(6):e21664
- FASEB J, 2021 35(7):e21725
- Biochim Biophys Acta Mol Cell Biol Lipids, 2021 1866(6):158920
- Ann Transl Med, 2021 9(5):384
- Molecules, 2021 26(8)2204
- Development, 2021 148(12)dev198275
- Sci Rep, 2021 11(1):15410
- Neurochem Res, 2021 10.1007/s11064-021-03276-3
- Food Chem Toxicol, 2021 152:112178
- J Endod, 2021 47(3):458-465
- Front Physiol, 2021 12:778982
- Clin Transl Sci, 2021 14(2):568-581
- Mol Immunol, 2021 137:1-10
- Toxicol In Vitro, 2021 77:105233
- Front Vet Sci, 2021 8:725386
- J Vasc Surg Venous Lymphat Disord, 2021 S2213-333X(21)00430-3
- Urolithiasis, 2021 10.1007/s00240-021-01292-0
- Neural Plast, 2021 2021:4894881
- Chin J Integr Med, 2021 10.1007/s11655-021-3304-y
- Mol Biol Rep, 2021 10.1007/s11033-021-06919-4
- Exp Ther Med, 2021 22(3):1003
- Exp Ther Med, 2021 22(6):1414
- Dent Mater J, 2021 10.4012/dmj.2020-354
- Sci Adv, 2021 7(33)eabf4416
- Sci Adv, 2021 7(16)eabb2213
- Sci Adv, 2021 7(3)eaba8053
- Stem Cell Res, 2021 52:102240
- STAR Protoc, 2021 2(1):100346
- STAR Protoc, 2021 2(2):100556
- Brain Commun, 2021 3(4):fcab223
- Cell Regen, 2021 10(1):30
- Sci Transl Med, 2020 12(554):eaax9276
- Nat Commun, 2020 11(1):5079
- Nat Commun, 2020 11(1):3344
- Nat Commun, 2020 11(1):382
- Nat Commun, 2020 11(1):3282
- Mol Neurodegener, 2020 15(1):61
- J Exp Clin Cancer Res, 2020 39(1):145
- Proc Natl Acad Sci U S A, 2020 117(40):25092-25103
- Genes Dev, 2020 10.1101/gad.332494.119
- Haematologica, 2020 Online ahead of print:0
- Cell Death Dis, 2020 11(10):931
- Cell Death Dis, 2020 11(8):647
- Cell Rep, 2020 32(1):107870
- Cell Rep, 2020 33(1):108221
- Chemosphere, 2020 6;254:126709
- Cell Rep, 2020 5;31(5):107600
- Cell Rep, 2020 12;31(6):107631
- Anesthesiology, 2020 30
- Anesthesiology, 2020 132(6):1540-1553
- Arterioscler Thromb Vasc Biol, 2020 40(4):958-972
- Cell Prolif, 2020 10.1111/cpr.12932
- Int J Biol Macromol, 2020 151:545-553
- Cell Mol Life Sci, 2020 10.1007/s00018-020-03630-8
- Stem Cell Res Ther, 2020 11(1):347
- Stem Cell Res Ther, 2020 11(1):386
- Stem Cell Res Ther, 2020 11(1):488
- Stem Cell Res Ther, 2020 11(1):67
- Oncogenesis, 2020 9(10):87
- Mol Autism, 2020 11(1):80
- Neural Regen Res, 2020 15(12):2335-2343
- Neurobiol Dis, 2020 105042
- Cells, 2020 9(10)E2209
- Cells, 2020 9(11)2422
- Cells, 2020 9(10)E2288
- Stem Cell Reports, 2020 15(2):408-423
- J Clin Endocrinol Metab, 2020 dgaa656
- J Cell Physiol, 2020 10.1002/jcp.29975
- Int J Mol Sci, 2020 21(22)E8693
- J Virol, 2020 94(21)e00603-20
- Exp Neurol, 2020 337:113574
- Am J Cancer Res, 2020 1;10(4):1238-1254 eCollection 2020
- J Neurosci, 2020 8;40(2):459-477
- J Cell Mol Med, 2020 10.1111/jcmm.15665
- Stem Cells, 2020 10.1002/stem.3316
- Stem Cells, 2020 10.1002/stem.3156
- Cancers (Basel), 2020 21;12(4) pii: E1019
- Aging (Albany NY), 2020 12(9):7747-7760
- Aging (Albany NY), 2020 5;12(9):7927-7944
- Aging (Albany NY), 2020 12(1):481-501
- Lab Invest, 2020 100(3):438-453
- Mol Pharm, 2020 17(11):4152-4162
- Skelet Muscle, 2020 2;10(1):13
- Am J Physiol Lung Cell Mol Physiol, 2020 318(4):L671-L683
- FASEB J, 2020 10.1096/fj.202000253RR
- FASEB J, 2020 34(5):7178-7191
- J Biol Chem, 2020 295(50):17114-17127
- J Biol Chem, 2020 jbc.RA120.014709
- J Biol Chem, 2020 jbc.RA120.015165
- J Biol Chem, 2020 jbc.RA120.14887
- FASEB J, 2020 34(4):5363-5388
- Carcinogenesis, 2020 41(7):993-1004
- Sci Rep, 2020 10(1):11828
- Environ Toxicol, 2020 9
- Biology (Basel), 2020 9(7):143
- Int J Biochem Cell Biol, 2020 S1357-2725(20)30219-3
- Pharm Biol, 2020 58(1):1244-1251
- BMC Cancer, 2020 20(1):597
- Cytokine, 2020 S1043-4666(20)30392-6
- AIDS, 2020 1;34(8):1141-1149
- Biomed Res Int, 2020 2020:3516128
- Mol Brain, 2020 13(1):125
- Cell Biochem Funct, 2020 38(1):38-46
- Mol Med Rep, 2020 21(3):1581-1589
- J Nat Med, 2020 19
- Brain Sci, 2020 3;10(6):E344
- Exp Ther Med, 2020 20(4):3661-3668
- PeerJ, 2020 8:e10104
- Gen Comp Endocrinol, 2020 301:113658
- Neurosci Lett, 2020 18;716:134681
- Physiol Rep, 2020 8(13):e14490
- Neurosci Lett, 2020 135201
- Sci Adv, 2020 6(30):eaba7606
- Stem Cell Res, 2020 49:102027
- Curr Protoc Stem Cell Biol, 2020 55(1):e120
- Kidney Int, 2019 96(4):927-941
- Nat Commun, 2019 10(1):3933
- Nat Commun, 2019 10(1):928
- Nat Commun, 2019 10(1):2612
- J Exp Med, 2019 216(12):2819-2837
- Mol Ther, 2019 10.1016/j.ymthe.2019.08.011
- Theranostics, 2019 9(5):1387-1400
- Clin Cancer Res, 2019 10.1158/1078-0432.CCR-18-4145
- Cancer Res, 2019 79(11):2853-2864
- Cancer Res, 2019 10.1158/0008-5472.CAN-18-3210
- EMBO Mol Med, 2019 11(8):e9830
- EBioMedicine, 2019 50:224-237
- EBioMedicine, 2019 42:252-269
- Am J Hum Genet, 2019 104(5):815-834
- Cancer Lett, 2019 452:79-89
- Pharmacol Res, 2019 143:73-85
- Cell Death Dis, 2019 10(6):458
- J Cachexia Sarcopenia Muscle, 2019 10.1002/jcsm.12489
- Cell Rep, 2019 26(13):3643-3656
- Cell Prolif, 2019 52(3):e12591
- Cell Prolif, 2019 52(4):e12631
- Cell Commun Signal, 2019 17(1):45
- Mucosal Immunol, 2019 12(3):656-667
- NPJ Precis Oncol, 2019 3:24
- Elife, 2019 8e45976
- Cell Biosci, 2019 9:24
- Blood Adv, 2019 3(18):2751-2763
- Blood Adv, 2019 3(14):2093-2104
- Stem Cell Res Ther, 2019 10(1):364
- Stem Cell Res Ther, 2019 10(1):172
- Stem Cell Res Ther, 2019 10(1):91
- Free Radic Biol Med, 2019 134:617-629
- Front Immunol, 2019 10:1988
- Sci Signal, 2019 12(599)
- Acta Neuropathol Commun, 2019 7(1):192
- Cell Death Discov, 2019 5:109
- J Bone Miner Res, 2019 10.1002/jbmr.3871
- Lab Chip, 2019 19(6):948-958
- Stem Cell Reports, 2019 13(2):338-351
- Stem Cell Reports, 2019 10.1016/j.stemcr.2019.08.004
- Stem Cell Reports, 2019 13(3):485-498
- Mol Cancer Ther, 2019 10.1158/1535-7163.MCT-19-0181
- J Neurosci, 2019 39(12):2184-2194
- Mol Cancer Res, 2019 17(8):1748-1758
- Stem Cells, 2019 37(7):958-972
- Stem Cells, 2019 10.1002/stem.3096
- Mol Neurobiol, 2019 10.1007/s12035-019-01802-7
- Skelet Muscle, 2019 9(1):8
- J Biol Chem, 2019 294(37):13657-13670
- Sci Rep, 2019 9(1):1897
- Molecules, 2019 24(6)
- Sci Rep, 2019 9(1):15935
- Front Neurosci, 2019 13:867
- Cell Cycle, 2019
- J Endod, 2019 45(5):599-605.e1
- J Cell Sci, 2019 133(5)
- J Cell Biochem, 2019 120(10):16553-16566
- J Cell Biochem, 2019 120(1):977-987
- Cancer Med, 2019 8(4):1721-1730
- Onco Targets Ther, 2019 12:7809-7821
- J Cell Biochem, 2019 120(8):12500-12507
- J Peripher Nerv Syst, 2019 24(4):330-339
- Mol Genet Metab, 2019 127(2):158-165
- Toxicol Appl Pharmacol, 2019 379:114685
- ACS Comb Sci, 2019 21(12):805-816
- PLoS One, 2019 14(10):e0223724
- Exp Cell Res, 2019 385(1):111670
- J Cancer Res Clin Oncol, 2019 145(2):411-427
- Front Neuroanat, 2019 13:23
- Math Biosci Eng, 2019 16(5):4607-4621
- Am J Transl Res, 2019 11(9):5546-5559
- Exp Lung Res, 2019 45(8):221-235
- Stem Cell Res, 2019 34:101368
- Stem Cell Res, 2019 34:101349
- Methods Mol Biol, 2019 1919:187-197
- Cell Regen (Lond), 2019 8(1):1-8
- Nat Commun, 2018 9(1):1463
- Nat Commun, 2018 9(1):2643
- Neuron, 2018 97(6):1235-1243
- Mol Cell, 2018 69(4):689-698
- Mol Neurodegener, 2018 13(1):33
- Theranostics, 2018 8(10):2846-2861
- EMBO J, 2018 37(2):282-299
- Cancer Res, 2018 78 (13): 3469–3483.
- Cancer Res, 2018 78(13):3469-3483
- Cancer Immunol Res, 2018 6(10):1246-1259
- Acta Biomater, 2018 78:274-284
- ACS Appl Mater Interfaces, 2018 10(35):29238-29250
- Cell Death Dis, 2018 9(9):849
- Cell Rep, 2018 25(7):1966-1981.e4
- Diabetologia, 2018 61(10):2202-2214
- Oncogene, 2018 37(1):128-138
- Int J Cancer, 2018 143(10):2561-2574
- Biochim Biophys Acta Mol Basis Dis, 2018 1864(11):3754-3768
- Oncogenesis, 2018
- Glia, 2018 66(1):145-160
- Stem Cell Reports, 2018 10(5):1481-1491
- Stem Cell Reports, 2018 11(1):183-196
- Cancer Sci, 2018 109(3):642-655
- J Am Heart Assoc, 2018 7(16):e008842
- Front Cell Neurosci, 2018 12:205
- Biochim Biophys Acta Mol Cell Res, 2018 1865(9):1239-1249
- Front Aging Neurosci, 2018 10:208
- PLoS Genet, 2018 14(7):e1007485
- Am J Physiol Gastrointest Liver Physiol, 2018 315(6):G909-G920
- Cell Physiol Biochem, 2018 48(3):1215-1229
- Oncol Rep, 2018 39(5):2081-2090
- Bone, 2018 109:218-224
- J Immunol Res, 2018 2018:6285813
- J Ovarian Res, 2018 11(1):6
- Toxicol Sci, 2018 166(2):394-408
- Cytokine, 2018 106:45-53
- Exp Cell Res, 2018 371(1):238-249
- Dev Comp Immunol, 2018 88:144-151
- Neurosci Lett, 2018 687:99-103
- Laryngoscope Investig Otolaryngol, 2018 3(5):337-344
- Stem Cell Res, 2018 32:25-34
- Curr Protoc Stem Cell Biol, 2018 44:2D.21.1-2D.21.17
- Curr Protoc Hum Genet, 2018 10.1002/cphg.64
- Nat Commun, 2017 8:15628
- Nat Commun, 2017 8:15166
- Biomaterials, 2017 143:57-64
- Theranostics, 2017 7(12):3053-3067
- Cell Death Differ, 2017 24(5):785-797
- Dev Cell, 2017 42(6):600-615.e4
- Am J Hum Genet, 2017 101(6):874-887
- Basic Res Cardiol, 2017 112(4):47
- Biofabrication, 2017 9(2):025007
- Cell Death Dis, 2017 8(8):e3027
- Br J Cancer, 2017 117(5):675-684
- Br J Cancer, 2017 117(2):233-244
- Stem Cell Res Ther, 2017 8(1):258
- J Transl Med, 2017 15(1):176
- Acta Neuropathol Commun, 2017 5(1):77
- Stem Cells Transl Med, 2017 6(9):1803-1814
- Stem Cells Transl Med, 2017 6(2):527-538
- Am J Pathol, 2017 187(8):1717-1735
- Stem Cells Transl Med, 2017 6(3):886-896
- Stem Cell Reports, 2017 8(2):264-277
- Stem Cell Reports, 2017 9(3):883-896
- Am J Chin Med, 2017 45(5):1061-1074
- Respir Res, 2017 18(1):46
- Oncotarget, 2017 8(50):87174-87181
- Biochim Biophys Acta Mol Cell Res, 2017 1864(7):1207-1216
- Sci Rep, 2017 7(1):12233
- Sci Rep, 2017 7(1):14727
- Sci Rep, 2017 7:42937
- Sci Rep, 2017 7:40191
- Mediators Inflamm, 2017 2017:7682083
- Sci Rep, 2017 7(1):13469
- Sci Rep, 2017 7(1):3989
- Stem Cells Int, 2017 2017:1960965
- Cell Cycle, 2017 16(10):1008-1014
- Neurochem Int, 2017 106:48-61
- Insect Biochem Mol Biol, 2017 87:165-173
- PLoS One, 2017 12(9):e0184155
- PLoS One, 2017 12(6):e0178533
- PLoS One, 2017 12(9):e0183972
- PLoS One, 2017 12(7):e0180834
- PLoS One, 2017 12(1):e0170674
- PLoS One, 2017 12(5):e0177188
- Exp Cell Res, 2017 355(2):142-152
- Mol Med Rep, 2017 15(5):2560-2566
- Pancreas, 2017 46(9):1202-1207
- Toxicol Res (Camb), 2017 6(2):215-222
- Nat Commun, 2016 7:11123
- Int J Nanomedicine, 2016 11:373-86
- Diabetes, 2016 65(1):96-109
- Biomed Pharmacother, 2016 84:535-543
- NPJ Regen Med, 2016 10.1038/npjregenmed
- Respirology, 2016 21(6):1075-80
- Cancer Sci, 2016 107(3):274-80
- Int J Mol Med, 2016 38(4):1225-34
- Oncotarget, 2016 7(50):82836-82850
- Oncotarget, 2016 7(43):70152-70167
- Oncotarget, 2016 7(4):4252-64
- Oncotarget, 2016 7(7):7979-92
- J Cell Mol Med, 2016 20(8):1542-9
- Front Cell Neurosci, 2016 10:291
- Biochim Biophys Acta, 2016 1863(8):2104-14
- Sci Rep, 2016 6:37534
- Development, 2016 143(23):4394-4404
- Sci Rep, 2016 6:30904
- Sci Rep, 2016 6:23828
- Sci Rep, 2016 6:21112
- PLoS Genet, 2016 12(9):e1006279
- Stem Cells Dev, 2016 25(1):1-12
- Stem Cells Dev, 2016 25(20):1591-1603
- J Cell Sci, 2016 129(15):2925-36
- Arch Biochem Biophys, 2016 596:43-50
- Mol Med Rep, 2016 14(2):1309-15
- Biomicrofluidics, 2016 10(1):014106
- Biochem Biophys Res Commun, 2016 10.1016/j.bbrc.2016.06.077
- Med Sci Monit, 2016 22:1161-70
- Comp Biochem Physiol A Mol Integr Physiol, 2016 198:15-21
- J Lab Autom, 2016 21(4):557-67
- Stem Cell Res, 2016 17(3):564-567
- J Clin Invest, 2015 125(8):3226-40
- J Clin Invest, 2015 125(2):796-808
- Nat Protoc, 2015 10(7):959-73
- J Autoimmun, 2015 63:76-87
- Cell Death Dis, 2015 6:e1824
- Liver Int, 2015 35(4):1222-33
- Stem Cells Transl Med, 2015 4(11):1275-82
- Oncotarget, 2015 6(35):37054-65
- Stem Cells, 2015 33(2):403-15
- Int J Oncol, 2015 47(1):122-32
- Mol Neurobiol, 2015 10.1007/s12035-014-9084-z
- Lab Invest, 2015 95(11):1234-45
- Methods, 2015 S1046-2023(15)30081-5
- Sci Rep, 2015 5:14733
- Sci Rep, 2015 5:11924
- PLoS One, 2015 10(1):e0115524
- PLoS One, 2015 10(6):e0129561
- Dig Dis Sci, 2015 60(1):127-35
- Evid Based Complement Alternat Med, 2015 2015:821947
- Chromosome Res, 2015 23(4):733-52
- Am J Transl Res, 2015 7(11):2364-78
- Parasitol Res, 2015 114(11):4251-7
- Stem Cell Res, 2015 15(1):141-50
- Methods Mol Biol, 2015 1299:103-14
- Proc Natl Acad Sci U S A, 2014 111(4):E465-73
- Genes Dev, 2014 28(8):858-74
- Cancer Lett, 2014 342(1):82-91
- Acta Biomater, 2014 10(7):3108-16
- J Virol, 2014 88(17):9877-92
- Int J Mol Med, 2014 34(5):1323-34
- Development, 2014 141(19):3683-96
- BMC Cancer, 2014 14(1):477
- PLoS One, 2014 9(2):e89553
- Toxicol Lett, 2014 226(2):150-62
- Cell Mole Bioeng, 2014 10.1007/s12195-014-0333-z
- Cell Mol Bioeng, 2014 7(2):172-183
- Integr Biol, 2014 6(1):44-52
- J Asian Nat Prod Res, 2014 16(6):658-66
- J Clin Invest, 2013 123(8):3564-76
- Proc Natl Acad Sci USA, 2013 110(52):E5039-48
- Am J Respir Cell Mol Biol, 2013 49(4):582-91
- J Biol Chem, 2013 288(11):7841-56
- Development, 2013 140(3):660-6
- PLoS Comput Biol, 2013 9(2):e1002887
- Stem Cells Dev, 2013 22(1):114-23
- Exp Biol Med (Maywood), 2013 238(3):276-84
- Arch Dermatol Res, 2013 305(5):433-45
- Eur Cytokine Netw, 2013 24(4):139-47
- Am J Physiol Heart Circ Physiol, 2012 302(11):H2211-9
- Gen Comp Endocrinol, 2012 178(2):314-22
- Anticancer Res, 2012 32(3):799-806
- Biochem Biophys Res Commun, 474(2):303-8
化学信息&溶解度
分子量 | 384.39 |
分子式 | C22H16N4O3 |
CAS号 | 301836-41-9 |
Smiles | C1OC2=C(O1)C=C(C=C2)C3=C(NC(=N3)C4=CC=C(C=C4)C(=O)N)C5=CC=CC=N5 |
储存条件(自收到货起) | |
建议分装储备液,避免反复冻融! |
|
体外溶解度 | 批次: |
DMSO : 77 mg/mL ( 200.31 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Ethanol : 3 mg/mL Water : Insoluble DMSO : 77 mg/mL ( 200.31 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Ethanol : 77 mg/mL Water : Insoluble DMSO : 77 mg/mL ( 200.31 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Ethanol : 3 mg/mL Water : Insoluble DMSO : 77 mg/mL ( 200.31 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Water : Insoluble Ethanol : Insoluble DMSO : 77 mg/mL ( 200.31 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Ethanol : 5 mg/mL Water : Insoluble |
体内溶解度 | 批次: |
现配现用,请按从左到右的顺序依次添加,澄清后再加入下一溶剂 | |
0.1%DMSO
99.80% Saline
浓度:0.02mg/ml
(0.05mM)
操作示例:以1 mL工作液为例,取1 μL20mg/ml的澄清DMSO储备液加到998 μL生理盐水中,混合均匀。工作液请现配现用!
|
|
5%DMSO
95% Corn oil
浓度:4mg/ml
(10.41mM)
操作示例:以1 mL工作液为例,取 50 μL 80 mg/mL 的澄清 DMSO 储备液加到 950 μL玉米油中,混合均匀。工作液请现配现用!
|
|
5%DMSO
40%PEG 300
5%Tween80
50% ddH2O
浓度:4mg/ml
(10.41mM)
操作示例:以 1 mL 工作液为例,取 50μL 80 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀使其澄清;向上述体系中加入50 μL Tween-80,混合均匀使其澄清;然后继续加入 500 μLddH2O定容至 1 mL。工作液请现配现用!
|
摩尔浓度计算器
质量(g)= 浓度(mol/L)* 体积(L)* 分子量(g/mol)
动物体内配方计算器(澄清溶液)
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,注:如该浓度超过该批次药物DMSO溶解度,请先联系Selleck);
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入 μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。
体内配方配制方法:取 μL DMSO母液,加入 μL Corn oil,混匀澄清。
注意:
1. 首先保证母液是澄清的;
2.一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。